NCT01623466View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Healthy

Interventions

DRUG

levonorgestrel

transdermal contraceptive delivery system

Sponsors

Lead Sponsor

Agile Therapeutics

All Listed Sponsors

lead

Agile Therapeutics

INDUSTRY

NCT01623466 - Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches | Biotech Hunter | Biotech Hunter